Literature DB >> 9683184

Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas.

J Mattern1, R Koomägi, M Volm.   

Abstract

Eighty-three non-small cell lung carcinomas (NSCLC) of previously untreated patients were analysed for expression of O6-methylguanine-DNA methyltransferase (MGMT) by means of immunohistochemistry. Expression of MGMT was detected in 62 of 83 tumours (75%). There was a significant difference in MGMT staining between smokers and non-smokers (P = 0.001). Tumours of smokers expressed more frequently MGMT than tumours of non-smokers. There was a trend of MGMT expression to be higher in tumours of patients smoking >20 cigarettes/day than patients smoking <20 cigarettes/day. Abstinence from smoking resulted in a significant decrease in MGMT expression (lin reg r = -0.59, P < 0.05). These results demonstrate that MGMT expression in human lung carcinomas is influenced by smoking habits of the patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683184     DOI: 10.1093/carcin/19.7.1247

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

1.  Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research.

Authors:  Zachary D Nagel; Isaac A Chaim; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2014-04-26

2.  The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.

Authors:  Zhenhua Lin; Meihua Gao; Xianglan Zhang; Young-Sik Kim; Eung-Seok Lee; Han-Kyeom Kim; Insun Kim
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

3.  Promoter hypermethylation of DNA repair gene MGMT in laryngeal squamous cell carcinoma.

Authors:  Song Zhang; Changkai Guo; Weijia Kong; Zheng Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.

Authors:  Jorge G Gomez-Gutierrez; Jonathan Nitz; Rajesh Sharma; Stephen L Wechman; Eric Riedinger; Elvis Martinez-Jaramillo; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2015-11-09       Impact factor: 3.616

5.  Immunohistochemical Assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers.

Authors:  Kyung Eun Lee
Journal:  J Cancer Prev       Date:  2013-12

6.  Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers.

Authors:  Hiroyuki Hayashi; Takuya Yazawa; Koji Okudela; Jun-ichi Nagai; Takaaki Ito; Masayoshi Kanisawa; Hitoshi Kitamura
Journal:  Jpn J Cancer Res       Date:  2002-02

7.  Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.

Authors:  Shinichi Matsuda; Aki Mafune; Nagisa Kohda; Takanori Hama; Mitsuyoshi Urashima
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

8.  Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions.

Authors:  W A Cooper; M R J Kohonen-Corish; C Chan; S Y Kwun; B McCaughan; C Kennedy; R L Sutherland; C-S Lee
Journal:  Histopathology       Date:  2008-04       Impact factor: 5.087

9.  Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).

Authors:  Arshad A Pandith; Iqbal Qasim; Wani Zahoor; Parveen Shah; Abdul R Bhat; Dheera Sanadhya; Zafar A Shah; Niyaz A Naikoo
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

10.  Protein expression profiles indicative for drug resistance of non-small cell lung cancer.

Authors:  M Volm; R Koomägi; J Mattern; T Efferth
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.